Genetic Technologies Limited (GENE)
NASDAQ: GENE · IEX Real-Time Price · USD
1.370
-0.040 (-2.84%)
Jul 2, 2024, 4:00 PM EDT - Market closed
Genetic Technologies Market Cap
Genetic Technologies has a market cap or net worth of $6.04 million as of July 2, 2024. Its market cap has decreased by -55.27% in one year.
Market Cap
6.04M
Enterprise Value
3.81M
1-Year Change
-55.27%
Ranking
Category
Stock Price
$1.37
Market Cap Chart
Since September 6, 2005, Genetic Technologies's market cap has decreased from $144.90M to $6.04M, a decrease of -95.83%. That is a compound annual growth rate of -15.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2024 | 300.00K | -40.00% |
| Dec 29, 2023 | 500.00K | -96.50% |
| Dec 30, 2022 | 14.30M | -49.47% |
| Dec 31, 2021 | 28.30M | -42.94% |
| Dec 31, 2020 | 49.60M | 411.34% |
| Dec 31, 2019 | 9.70M | 8.99% |
| Dec 31, 2018 | 8.90M | -52.66% |
| Dec 29, 2017 | 18.80M | 51.61% |
| Dec 30, 2016 | 12.40M | -59.48% |
| Dec 31, 2015 | 30.60M | 287.34% |
| Dec 31, 2014 | 7.90M | -65.20% |
| Dec 31, 2013 | 22.70M | -32.84% |
| Dec 31, 2012 | 33.80M | -17.36% |
| Dec 30, 2011 | 40.90M | 188.03% |
| Dec 31, 2010 | 14.20M | -1.39% |
| Dec 31, 2009 | 14.40M | 13.39% |
| Dec 31, 2008 | 12.70M | -73.76% |
| Dec 31, 2007 | 48.40M | -49.69% |
| Dec 29, 2006 | 96.20M | -12.39% |
| Dec 30, 2005 | 109.80M | -24.22% |
View and export this data all the way back to 2005.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cadrenal Therapeutics | 7.52M |
| NeuroMetrix | 7.42M |
| Biomerica | 7.40M |
| PolyPid | 7.11M |
| Pulmatrix | 7.05M |
| ENDRA Life Sciences | 6.82M |
| Shuttle Pharmaceuticals Holdings | 6.71M |
| TransCode Therapeutics | 6.60M |